4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001771961-26-000006
Chief Accounting Officer sold 2,827 shares at $30.00 ($84,810)
- Chief Accounting Officer acquired 2,827 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Azoy Alexander · Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,827 | $15.44 | $43,649 | 42,408 | D |
| 2026-08-21 | Sale : show line 2 in the form 10b5-1 | −2,827 | $30.00 | $84,810 | 39,581 | D |
| Open-market sales · 2,827 sh · avg $30.00 · $84,810 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-21 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −2,827 | 3,073 | D |
Loading xslF345X06/wk-form4_1787608336.xml…